FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely neurology, and may be used for treating complications caused by herpetic meningoencephalitis. A therapeutic effect is ensured by the endolumbar introduction of 1000000 autologous mesenchymal stem cells followed by the intramuscular introduction of ribonucleic acid hydrolysate 100 mg in one injection daily in the therapeutic course of 30 days.
EFFECT: use of the given method enables faster and more effective recovery of patient's cerebral functions.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING THE DISEASES OF DIFFERENT ETIOLOGY AND TRAUMAS OF DIFFERENT ORGANS | 2005 |
|
RU2301667C1 |
METHOD FOR PRODUCTION OF CELL CULTURE FOR TREATMENT OF VASCULAR DEMYELINATING DISEASES OF NERVOUS SYSTEM AND CELL CULTURE PRODUCED BY THIS METHOD (VERSIONS) | 2007 |
|
RU2347579C1 |
CORRECTION METHOD OF FUNCTIONAL ORGANISM'S DEFECTS CAUSED BY DAMAGED NERVE CELLS OF BRAIN | 2007 |
|
RU2368378C1 |
COMPOSITION FOR SKIN AND MUCOUS MEMBRANES REGENERATION | 2016 |
|
RU2621867C1 |
METHOD FOR STIMULATING SPINAL CORD REGENERATION BY MESENCHYMAL STEM CELLS, WHICH ARE INCLUDED IN THE FIBRIN MATRIX | 2016 |
|
RU2650638C1 |
BIOMEDICAL CELL PRODUCT FOR TREATING NERVOUS DISEASES AND MENTAL DISORDERS, METHOD FOR PRODUCTION THEREOF AND USE THEREOF | 2018 |
|
RU2720002C1 |
METHOD FOR TREATMENT OF BRAIN CONFUSION | 2007 |
|
RU2347578C1 |
BIOTRANSPLANT AND METHOD FOR TREATING ISCHEMIC INSULT | 2004 |
|
RU2258521C1 |
METHOD FOR TREATING STROKE CASES | 2004 |
|
RU2283121C2 |
COMPOSITIONS FOR TREATING TISSUE INJURIES | 2016 |
|
RU2721116C2 |
Authors
Dates
2012-12-27—Published
2011-05-25—Filed